Inovio Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 59 Posts
1 2 3 4
E Market Briefing For Monday, Aug. 31
Article By: Gene Inger Sunday, August 30, 2020 8:03 PM EDT
This continues our case for continued erratic behavior (rotating on news too); but not catastrophe, even if you get a shakeout of juggernauts along the way.
In this article: SPX, ABT, BMY, PFE, INO, SRNE, MRNA, HTBX, VXRT
Read
Quick Reminder: Insider Trading Does Not Maximize Shareholder Value
Article By: Dean Baker Sunday, July 26, 2020 7:39 PM EDT
Insider trading effectively means top executives are stealing from the companies they run. Excitement over potential covid vaccines may be causing irregularities at at least 9 biopharmas, according to the NYT.
In this article: VXRT, REGN, MRNA, NVAX, LMNX, QDEL, EBS, INO
Read
Week In Review: How Trump's Policies Moved Stocks - Saturday, July 4
Article By: The Fly Saturday, July 4, 2020 7:35 PM EDT
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap.
In this article: ROSLB, ACM, BBY, CAG, CAT, CLX, EXP, F, FLR, GVA, HMC, HPQ, KO, MLM, PEP, PFE, PG, PWR, SAP, SIX, TGT, UL, VMC, VZ, INO, USCR, ADDYY, AMZN, DNKN, FOSL, MSFT, SBUX, DENN, MRNA, FB, J, BNTX
Read
Analyst Says Sell Inovio On 'Unimpressive' COVID Vaccine Data
Article By: The Fly Wednesday, July 1, 2020 12:20 PM EDT
Maxim also downgraded Inovio to Hold following interim results for its COVID-19 vaccine candidate.
In this article: INO Also: PFE, BNTX
Read
Roth 'Unimpressed' With Inovio Data, Downgrades To Sell With $11 Target
Article By: The Fly Wednesday, July 1, 2020 9:24 AM EDT
Roth Capital analyst Jonathan Aschoff downgraded Inovio Pharmaceuticals to Sell from Neutral with an unchanged price target of $11.
In this article: INO
Read
8 Stock Catalysts For The Week Ahead
Article By: Benzinga Sunday, June 28, 2020 6:02 PM EDT
The S&P 500 finished off a difficult week on a low note June 26, after another turbulent week on Wall Street. Here are eight potential catalysts for the week ahead that could move the markets.
In this article: FDX, M, DNB, F, GM, INO, ADNW, SPY Also: SPX
Read
Volatile Week For Coronavirus Stocks: COVID Vaccines Are In Focus
Article By: Rod Raynovich Sunday, June 28, 2020 1:41 PM EDT
Friday was a risk-off day for biotech stocks as the XBI​ took a 3.28% hit on profit taking and concerns that the pandemic could drag on through the summer.
In this article: INO, NVAX, QDEL, XBI, MRNA, VIR, BNTX
Read
Inovio Downgraded To Hold From Buy At Stifel
Article By: The Fly Friday, June 26, 2020 6:43 AM EDT
Stifel analyst Stephen Willey downgraded Inovio Pharmaceuticals to Hold from Buy with a price target of $24, up from $19.
In this article: INO
Read
After-Hours Movers
Article By: The Fly Thursday, June 25, 2020 10:11 PM EDT
Check out this evening's top movers from around Wall Street: Nike retreats after Q4 earnings loss and initial FY21 outlook calling for revenue to be flat to slightly up; and more.
In this article: IAC, NKE, SNX, INO, MTCH, CAMP, PRGS, DKNG, SOLY
Read
Stock Charts To Watch - Monday, June 15
Video By: Harry Boxer Monday, June 15, 2020 8:41 PM EDT
Inovio Pharmaceuticals, Inc. also may have popped on Monday and took out the declining topsline and prior highs.
In this video: VBIV, NVAX, SEED, INO, CLSN
Watch
Week In Review: How Trump's Policies Moved Stocks - Saturday, June 6
Article By: The Fly Saturday, June 6, 2020 5:31 PM EDT
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap.
In this article: L, AZN, CEA, DAL, JNJ, MRK, PFE, UAL, ZNH, INO, AIRYY, NVAX, AAPL, AMZN, GOOG, MRNA, SNAP, FB, AAL, GOOGL
Read
These Are Some Of The Coronavirus Vaccine Candidates
Article By: ValueWalk Monday, May 25, 2020 6:28 PM EDT
As far as which coronavirus vaccine candidates will be tested first, researchers will look at production capacity and the amount of immune response generated in early trials and animal studies.
In this article: GSK, PFE, SNY, MRNA, ALT, JNJ, SVA, NVAX, INO, AZN
Read
Inovio Q1 Results Miss Estimates, Coronavirus Vaccine Program On Track
Article By: Benzinga Monday, May 11, 2020 6:22 PM EDT
The Plymouth, Pennsylvania-based company reported a first-quarter net loss of $32.5 million or 26 cents per share compared to the year-ago loss of $29.2 million and 30 cents per share.
In this article: INO Also: AZN
Read
Inovio Pharmaceuticals Is COVID-19's Theranos: Citron
Article By: ValueWalk Wednesday, April 29, 2020 4:17 AM EDT
There is currently no "cure" for either COVID-19 or shareholders.
In this article: INO
Read
E Staying Long Against High-Frequency Traders
Article By: James Gornick Wednesday, April 22, 2020 11:10 AM EDT
Time to send the message for the Institutional Investors to run back into ownership--long positions, and bring the bullish goring of the short-selling bears on $INO to break their trading funds within their banks.
In this article: GSK, SNY, INO Also: REGN, MRNA
Read
5 Biotechs In Search Of A Coronavirus Vaccine
Article By: MoneyShow.com Friday, March 20, 2020 8:36 AM EDT
In serious situations like this, the FDA would certainly fast-track any promising cure or vaccine that is submitted. But even that implies a lengthy delay. Many companies are racing to be the first out of the gate. Here are some of them.
In this article: SNY, INO, REGN, GILD, MRNA
Read
1 to 16 of 59 Posts
1 2 3 4